Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies

Kallirroi Kotilea1, Nicolas Kalach2, Matjaž Homan3

  • 1Department of Pediatric Gastroenterology, Université Libre de Bruxelles, Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.

Paediatric Drugs
|May 23, 2018
PubMed

Insights

Helicobacter pylori infection in children often causes no symptoms but can lead to peptic ulcers and gastric cancer. Diagnosis requires endoscopy, and treatment should consider compliance and antibiotic resistance.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection acquired in childhood is a primary cause of peptic ulcer disease and gastric cancer.
  • Recent guidelines and post-2015 publications are reviewed, focusing on pediatric H. pylori management.
  • Most infected children are asymptomatic, and H. pylori is not linked to functional abdominal pain.

Purpose of the Study:

  • To provide commentary on the latest ESPGHAN/NASPGHAN guidelines for pediatric H. pylori infection.
  • To discuss the evolving understanding of H. pylori's role in childhood health conditions.
  • To outline current best practices for diagnosis and treatment of H. pylori in children.

Main Methods:

  • Review of the latest ESPGHAN/NASPGHAN guidelines.
  • Analysis of publications post-2015 consensus conference.
  • Synthesis of evidence regarding H. pylori's impact on pediatric health outcomes.

Main Results:

  • H. pylori is not associated with recurrent abdominal pain in children.
  • The link between H. pylori and failure to thrive, growth, type I diabetes mellitus (T1DM), and celiac disease remains debated.
  • Nodular gastritis is the common endoscopic finding; ulcers may occur in older children.

Conclusions:

  • Diagnosis relies on upper-digestive endoscopy with biopsies.
  • Treatment should be guided by antimicrobial susceptibility and expected patient compliance.
  • Eradication control should utilize validated non-invasive tests.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
330
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
307
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis01:24

Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis

The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
2.5K